A "dose on demand" Biomarker Generator for automated production of [18F]F- and [18F]FDG

Applied Radiation and Isotopes

Volumn 89, Issue , 2014, Pages 167-175

  Awasthi, V ^a   Watson, J ^b   Gali, H ^a   Matlock, G ^a   McFarland, A ^b   Bailey, J ^b   Anzellotti, A ^b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b ABT Molecular Imaging Inc   (United States)

Author keywords

Cyclotron; FDG; PET

Indexed keywords

AUTOMATION; CYCLOTRONS; MAMMALS; POLYETHYLENE TEREPHTHALATES; PROTON BEAMS; QUALITY ASSURANCE; QUALITY CONTROL; TUMORS;

AUTOMATED OPERATIONS; AUTOMATED PRODUCTIONS; AUTOMATED SYNTHESIS; FDG; HUMAN LUNG ADENOCARCINOMA CELLS; QUALITY CONTROL TESTS; RADIATION EXPOSURE; RADIOCHEMICAL PURITY;

FLUORINE;

ACETONITRILE; ALCOHOL; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; SOLVENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMATION; BIOMARKER GENERATOR; CARCINOMA CELL; CYCLOTRON; DEVICE SAFETY; DRUG MANUFACTURE; GENERATOR; GOOD MANUFACTURING PRACTICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMAGING SYSTEM; IRRADIATION; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; OPERATOR; PH; PRIORITY JOURNAL; PROTON RADIATION; QUALITY CONTROL; RADIATION EXPOSURE; RADIATION HAZARD; RELIABILITY; TUMOR MODEL; TUMOR VOLUME; TUMOR XENOGRAFT; ADENOCARCINOMA; ANIMAL; CHEMISTRY; DEVICES; DIAGNOSTIC USE; DISEASE MODEL; LUNG TUMOR; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; SYNTHESIS; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CYCLOTRONS; DISEASE MODELS, ANIMAL; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS;

EID: 84896294147     PISSN: 09698043     EISSN: 18729800     Source Type: Journal    
DOI: 10.1016/j.apradiso.2014.02.015     Document Type: Article

References (14)

1. Anzellotti A.I., McFarland A.R., Ferguson D., Olson K.F. Towards the full automation of QC release tests for [18F]fluoride-based radiotracers. Curr. Org. Chem. 2013, 17:2153-2158.
2. Arima V., Pascali G., Lade O., Kretschmer H.R., Bernsdorf I., Hammond V., Watts P., De Leonardis F., Tarn M.D., Pamme N., Cvetkovic B.Z., Dittrich P.S., Vasovic N., Duane R., Jaksic A., Zacheo A., Zizzari A., Marra L., Perrone E., Salvadori P.A., Rinaldi R. Radiochemistry on chip: towards dose-on-demand synthesis of PET radiopharmaceuticals. Lab Chip 2013, 13:2328-2336.
3. Bar-Shalom R., Yefremov N., Guralnik L., Gaitini D., Frenkel A., Kuten A., Altman H., Keidar Z., Israel O. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J. Nucl. Med. 2003, 44:1200-1209.
4. Bohnen N.I., Djang D.S., Herholz K., Anzai Y., Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J. Nucl. Med. 2012, 53:59-71.
5. Fletcher J.W., Djulbegovic B., Soares H.P., Siegel B.A., Lowe V.J., Lyman G.H., Coleman R.E., Wahl R., Paschold J.C., Avrill N., Einhorn L.H., Suh W.W., Samson'O D., Delbekell D., Gorman M., Shields A.F. Recommendations on the use of F-18-FDG PET in oncology. J. Nucl. Med. 2008, 49:480-508.
6. Food and Drug Administration, Guidance for Industry: Process Validation: General Principles and Practices, Rockville, MD; 2011 (Accessed Dec. 2013). http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070336.pdf.
7. Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 1986, 27:235-238.
8. Hoh C.K. Clinical use of FDG PET. Nucl. Med. Biol. 2007, 34:737-742.
9. Pant G.S., Senthamizhchelvan S. Initial experience with an 11MeV self-shielded medical cyclotron on operation and radiation safety. J. Med. Phys. 2007, 32:118-123.
10. Pascali G., Watts P., Salvadori P.A. Microfluidics in radiopharmaceutical chemistry. Nucl. Med. Biol. 2013, 40:776-787.
11. Ratib O., Beyer T. Whole-body hybrid PET/MRI: ready for clinical use?. Eur. J. Nucl. Med. Mol. Imaging 2011, 38:992-995.
12. Townsend D.W. Positron emission tomography/computed tomography. Semin. Nucl. Med. 2008, 38:152-166.
13. U.S. Pharmacopeial Convention, U.S. Pharmacopeia 34th ed., The National Formulary 29th ed., 2011.
14. U.S. Pharmacopeial Convention, U.S. Pharmacopeia 36th ed., The National Formulary 31st ed., General Chapter <71>Sterility Tests, 2013.